检疫性植物病原
'Candidatus Phytoplasma pruni' → Fieberiella florii → Grapevine flavescence dorée phytoplasma
RU A1 K-P 潜在
评分
四项指标均为无量纲。总分是特异性、寄主距离与可信度的乘积。
0.333
特异性
1 / 媒介上的病原数量——在 EPPO 中该媒介传播 3 种病原。
0.20
寄主距离
1.0 = 无共享寄主 · 0.5 = 共享科 · 0.2 = 共享属 · 0.0 = 共享种。
0.50
可信度 (K-P)
K = 已确认媒介(1.0),P = 潜在(0.5);两条边相乘。
0.033
总分
特异性 × 寄主距离 × 可信度
分布:Grapevine flavescence dorée phytoplasma
依据 EPPO Global Database 记录有存在的国家(23 个 ISO 代码)。
GBUYLTSKBEBGUSESNLMDROFRCZMERSSIATITPTHUHRCHDE
寄主植物:Grapevine flavescence dorée phytoplasma
依据 EPPO 的前 10 个寄主分类单元;类别依据 EPPO 寄主分类。
- Vitis vinifera VITVI Major host
- Clematis vitalba CLVVT Wild/Weed
- Ailanthus altissima AILAL Host
- Alnus 1ALUG Host
- Alnus glutinosa ALUGL Host
- Alnus incana ALUIN Host
- Corylus avellana CYLAV Host
- Salix sp. SAXSS Host
- Vitis acerifolia VITAC Host
- Vitis amurensis VITAM Host
同义名:Grapevine flavescence dorée phytoplasma
- Goldgelbe Vergilbung
- flavescence dorée of grapevine
- bacco 22A disease
- flavescence dorée phytoplasma
- flavescencia dorada de la vid
- flavescence dorée de la vigne
- rougeau
- flavescenza dorata de la vite
- Phytoplasma vitis
- 'Candidatus Phytoplasma vitis'
- flavescência dourada
- Фитоплазма золотистого пожелтения винограда
来源
'Candidatus Phytoplasma pruni' ↔ Fieberiella florii
* Lee IM, Gundersen-Rindal DE, Bertaccini A (1998) Phytoplasma: ecology and genomic diversity. Phytopathology 88, 1359–1366. * Olivier CY, Lowery DT, Stobbs LW (2009) Phytoplasma diseases and their relationships with insect and plant hosts in Canadian horticultural and field crops. Canadian Entomologist 141, 425-462.
Fieberiella florii ↔ Grapevine flavescence dorée phytoplasma
* Jarausch B, Abidon C, Biancu S, Salar P, Desqué D, Roques M, Runne M, Jarausch W, Markheiser A, Maixner M, Meistermann E (2026) The role of reservoir plants and alternative vectors for the spread of Flavescence dorée (FD) phytoplasmas in FD-free regions: Lamprotettix nitidulus identified as a new vector. Journal of Pest Science 99(1), 35. ----shown to carry Grapevine flavescence doree, no transmission trials.